If you'd invested in: Renishaw and GlaxoSmithKline

Measuring-equipment maker Renishaw has seen profits leap, but investors are sceptical about the prospects for drugmaker GSK.

If only...

885_Good

Renishaw (LSE:RSW) develops and sells high-technology precision measuring and calibration equipment. Over the past 12 months, it almost doubled its market value as results continue to impress. Revenues jumped 17% to £279.5m, while adjusted pre-tax profit leapt 72% higher to £62.3m. It now expects full-year revenues to cross the £600m mark for the first time. However, the shares slipped back in January when David McMurtry the firm's founder, largest shareholder, chairman and chief executive announced he was stepping down as chief executive.

Be glad you didn't

885_Bad

GlaxoSmithKline (LSE:GSK) is Britain's biggest drugmaker. Last July the company said it would offload more than 130 of its non-core brands as it extended a restructuring programme meant to deliver £1bn in annual cost savings by 2020. In October, the chief executive, Emma Walmsley who took over last April announced a 4% rise in third-quarter sales to £7.8bn, helped by demand for new HIV, lung and meningitis products. Operating profit rose 31% to £1.9bn. But investors remain sceptical about the sustainability of the firm's dividend and the shares slid further.

Recommended

How to profit from pampered pets beyond the pandemic
Share tips

How to profit from pampered pets beyond the pandemic

Covid-19 has greatly boosted ownership. But the market had been expanding for years, and demographic, cultural and medical trends all point to long-te…
30 Jul 2021
Japanese stocks offer plenty of promise at the right price
Japan stockmarkets

Japanese stocks offer plenty of promise at the right price

After decades of disappointment, Japan is packed with opportunities for investors, says Alex Rankine.
30 Jul 2021
Share tips of the week – 30 July
Share tips

Share tips of the week – 30 July

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
30 Jul 2021
Latest issue
Investments

Latest issue

Latest issue of MoneyWeek magazine
30 Jul 2021

Most Popular

Why the UK's 2.5% inflation is a big deal
Inflation

Why the UK's 2.5% inflation is a big deal

After years of inflation being a financial-assets problem, it is now an “ordinary things” problem too, says Merryn Somerset Webb. But central banks st…
16 Jul 2021
The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism
Economy

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism

Russell Napier talks to Merryn about financial repression – or "stealing money from old people slowly" – plus how Asian capitalism is taking over in t…
16 Jul 2021
Cryptocurrency roundup: Twitter founder’s “DeFi” platform
Bitcoin & crypto

Cryptocurrency roundup: Twitter founder’s “DeFi” platform

In crypto this week: regulators are getting worried; Jack Dorsey’s bitcoin DeFi platform; and dogecoin’s co-founder lambasts cryptocurrencies.  Salon…
16 Jul 2021